Hossam El Benawi on Impact of Timing of Atrial Fibrillation Ablation
Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared on LinkedIn:
”’Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF”:
Using TriNetX (2010–2024), we studied HF patients with AF (after HF onset)undergoing early (≤1 yr) vs delayed (1–3 yrs) ablation, (7654 HFrEF, 3033 HFpEF ):
- Delayed ablation was linked to higher AF recurrence in both HFpEF and HFrEF.
- In HFrEF, delayed ablation →
↑ Redo ablation, ↑ DCCV , ↑ AAD use - HFpEF, delayed ablation →
Redo ablation and DCCV, but↑ AAD use - No significant differences in:
Stroke, HF hospitalizations, All-cause hospitalizations, Mortality between early vs delayed ablation in both groups.
Study link.”
Read the full article here.
Article: Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF
Authors: Mahmoud Eisa, Hossam Elbenawi, Momina Iftikhar, Ahmed El Shaer, Muhammad Eltony, Omar Almaadawy, Amro Aglan, Mahmoud Samy Ahmed, Kareem A. Mohamed, Khaled Elfert, Mahmoud Shadi, Mohan Rao, Justin Z. Lee, Zain Ul Abideen Asad, Freddy Del-Carpio Munoz, Konstantinos C. Siontis, Mark S. Link, Abhishek J. Deshmukh, Christopher V. DeSimone
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 7, 2026, 13:57Joshua Muia: Delighted to Welcome X. Long Zheng for a Versiti Seminar on TTP
-
Jan 7, 2026, 13:40Marilena Vrana Invites You to IPPC2026
-
Jan 7, 2026, 13:32Carlos Villa Joins Versiti Blood Research Institute
-
Jan 7, 2026, 13:21Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25